ECM
PODD icon

Everence Capital Management’s Insulet PODD Stock Holding History

Everence Capital Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,278
Closed -$268K – 915
2026
Q1 		$268K Buy
1,278
+388
+44% +$97.5K 0.02% 636
2025
Q4 		$253K Sell
890
-1,698
-66% -$531K 0.02% 659
2025
Q3 		$799K Buy
2,588
+928
+56% +$291K 0.05% 281
2025
Q2 		$522K Sell
1,660
-460
-22% -$133K 0.03% 365
2025
Q1 		$557K Buy
2,120
+1,070
+102% +$290K 0.04% 341
2024
Q4 		$274K Buy
+1,050
New +$264K 0.02% 624

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Everence Capital Management's PODD Position: Q2 2026 in Review

Everence Capital Management sold out of Insulet (PODD) in Q2 2026, closing a stake of 1,278 shares — an estimated $268K sold.

Everence Capital Management first reported a position in PODD in Q4 2024 and held it in 6 quarters. The position peaked at $799K in Q3 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Everence Capital Management reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Everence Capital Management sold 1,278 Insulet shares in Q2 2026, an estimated $268K.
  • Everence Capital Management first reported a position in Insulet in Q4 2024 and held it in 6 quarters.
  • Everence Capital Management's Insulet position peaked at $799K in Q3 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.